Skip to main content

Asia IP, in their recent feature, “Months into the pandemic, what has been the effect on IP registration”, sought our Senior Partner, Safir Anand’s insights.

Safir stated, “While there is not an overall increase in filings, there is a rise in certain spheres of innovation, especially in pharma and digital technology which has eventually steered registrations in the supplementary trademark classes. With work-from-home becoming the new norm, businesses around the globe are testing and upgrading their technology infrastructure to give seamless work familiarity to their employees working remotely. The lack of physical experience and interaction in the market has also led to unique online experiences for the consumers.”

He added that the shift is not just limited to these industries, but that the education system is also moving towards digitalization with classes and examinations being held virtually. This change has led to a massive pool of innovation coming in. Similarly, on the pharma side, several businesses applying for trademarks of medicines, sanitizers, surgical equipment, masks, immunity boosters, electronic gadgets, etc. have boosted IP registrations to protect their inventions and innovations.

Read more here:

More from Safir Anand:

 

 

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on Chambers’ By: Dhruv Anand, Dhananjay Khanna and Bhavya Verma It will not be an exaggeration to say that there has been an explosion

PERSONALITY RIGHTS – CURRENT TRENDS
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on India Business Law Journal’ By: Shantanu Sahay and Pratyush Acharya As India moved towards full implementation of the Digital Personal

Treatment of legacy personal data under the DPDPA
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India